Consensus EPS · Q2 2026
-$0.11
Consensus revenue · Q2 2026
$0
Analysts
7
Expected report
Aug 12, 2026
What to watch
- Analyst ratings: Mixed
Analyst consensus
Based on estimates from 7 analysts.
| Metric | Low | Consensus | High |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| EPS | -$0.13 | -$0.11 | -$0.09 |
| EBITDA | $0 | $0 | $0 |
| EBIT | $0 | $0 | $0 |
| Net income | -$36.7M | -$33.9M | -$31.1M |
- Revenue$0
- EPS-$0.11
- EBITDA$0
- EBIT$0
- Net income-$33.9M
Estimate revisions
How analyst consensus estimates have changed over the past 90 days.
| Metric | Now | 30d ago | 60d ago | 90d ago | 30d Δ |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | — | — | — |
| EPS | -$0.11 | -$0.11 | — | — | +2.6% |
Community vs analysts
See how the TickerLeague crowd's forecast stacks up against Wall Street.
Be the first to predict
No community consensus for Erasca (ERAS) Q2 2026 yet. Make a prediction to start the crowd forecast.
Analyst price target
Based on price targets from 3 analysts.
- Low
- $16.00
- Consensus
- $22.83
- Median
- $22.50
- High
- $30.00
- Current
- $18.15
- Upside
- +25.8%
Upside calculated vs most recent trading price of $18.15.
Analyst ratings
Consensus: Buy — based on 11 analyst ratings.
24-month trend
Recent analyst actions
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 20, 2026 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| Jul 14, 2026 | B of A Securities | maintain | Neutral | Neutral |
| Jun 4, 2026 | B of A Securities | upgrade | Underperform | Neutral |
| May 12, 2026 | Mizuho | maintain | Outperform | Outperform |
| Apr 27, 2026 | Stifel | maintain | Buy | Buy |
| Mar 18, 2026 | JP Morgan | maintain | Overweight | Overweight |
| Mar 16, 2026 | Guggenheim | maintain | Buy | Buy |
| Mar 13, 2026 | Piper Sandler | maintain | Overweight | Overweight |
| Mar 13, 2026 | Mizuho | maintain | Outperform | Outperform |
| Mar 13, 2026 | HC Wainwright & Co. | maintain | Buy | Buy |
- Jul 20, 2026Morgan StanleyEqual Weight
- Jul 14, 2026B of A SecuritiesNeutral
- Jun 4, 2026B of A SecuritiesNeutral
- May 12, 2026MizuhoOutperform
- Apr 27, 2026StifelBuy
- Mar 18, 2026JP MorganOverweight
- Mar 16, 2026GuggenheimBuy
- Mar 13, 2026Piper SandlerOverweight
- Mar 13, 2026MizuhoOutperform
- Mar 13, 2026HC Wainwright & Co.Buy
Frequently asked questions
Erasca (ERAS) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.